175 related articles for article (PubMed ID: 38384402)
21. Atypical Presentation of Pregnancy-Related Hemolytic Uremic Syndrome.
Baghli S; Abendroth C; Farooq U; Schaub JA
Am J Kidney Dis; 2018 Sep; 72(3):451-456. PubMed ID: 29331477
[TBL] [Abstract][Full Text] [Related]
22. Atypical hemolytic-uremic syndrome due to complement factor I mutation.
Almalki AH; Sadagah LF; Qureshi M; Maghrabi H; Algain A; Alsaeed A
World J Nephrol; 2017 Nov; 6(6):243-250. PubMed ID: 29226095
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
[TBL] [Abstract][Full Text] [Related]
24. Atypical hemolytic uremic syndrome: when pregnancy leads to lifelong dialysis: a case report and literature review.
Cadet B; Meshoyrer D; Kim Z
Cardiovasc Endocrinol Metab; 2021 Dec; 10(4):225-230. PubMed ID: 34765894
[TBL] [Abstract][Full Text] [Related]
25. Eculizumab Maintenance and the Prevention of Atypical Hemolytic Uremic Syndrome Relapse During Pregnancy: A Case Report.
Winchester ML; Platzbecker R; McMahon M; Parrish M
J Med Cases; 2019 Dec; 10(12):343-344. PubMed ID: 34434305
[TBL] [Abstract][Full Text] [Related]
26. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Vondrák K; Seeman T
Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
[TBL] [Abstract][Full Text] [Related]
27. Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review.
Altaf F; Khanzada M; Qasim A; Anto AM; Haider A; Khaja M
Cureus; 2024 Apr; 16(4):e57973. PubMed ID: 38738120
[TBL] [Abstract][Full Text] [Related]
28. Atypical Hemolytic Uremic Syndrome Associated With Clostridium Difficile Infection.
Khurshid Q; Mahmoud A; Shahid M; Mohamed A; Shahbaz A
Cureus; 2020 Jul; 12(7):e9005. PubMed ID: 32775085
[TBL] [Abstract][Full Text] [Related]
29. Deleterious Impact of a Novel
Schönauer R; Seidel A; Grohmann M; Lindner TH; Bergmann C; Halbritter J
Front Genet; 2019; 10():465. PubMed ID: 31156713
[TBL] [Abstract][Full Text] [Related]
30. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.
Gaggl M; Aigner C; Csuka D; Szilágyi Á; Prohászka Z; Kain R; Haninger N; Knechtelsdorfer M; Sunder-Plassmann R; Sunder-Plassmann G; Schmidt A
J Am Soc Nephrol; 2018 Mar; 29(3):1020-1029. PubMed ID: 29282226
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
Shen YM
Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
[TBL] [Abstract][Full Text] [Related]
32. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
Rysava R; Peiskerova M; Tesar V; Benes J; Kment M; Szilágyi Á; Csuka D; Prohászka Z
Front Immunol; 2022; 13():1001366. PubMed ID: 36275662
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome.
Saad AF; Roman J; Wyble A; Pacheco LD
AJP Rep; 2016 Mar; 6(1):e125-8. PubMed ID: 26989566
[TBL] [Abstract][Full Text] [Related]
34. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
[TBL] [Abstract][Full Text] [Related]
35. Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis.
Kozlovskaya NL; Korotchaeva YV; Bobrova LA
J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2853-2859. PubMed ID: 29606012
[No Abstract] [Full Text] [Related]
36. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
[TBL] [Abstract][Full Text] [Related]
37. Clinical guides for atypical hemolytic uremic syndrome in Japan.
Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
[TBL] [Abstract][Full Text] [Related]
38. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
Avila Bernabeu AI; Cavero Escribano T; Cao Vilarino M
Nephron; 2020; 144(11):537-549. PubMed ID: 32950988
[TBL] [Abstract][Full Text] [Related]
39. Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab.
Chua J; Paizis K; He SZ; Mount P
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():18-22. PubMed ID: 28176472
[TBL] [Abstract][Full Text] [Related]
40. Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome.
Abughanimeh OK; Baljevic M; Nester A
Cureus; 2024 Jan; 16(1):e52633. PubMed ID: 38374836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
